- Report
- July 2024
- 100 Pages
Global
From €3471EUR$3,750USD£2,939GBP
- Report
- July 2024
- 150 Pages
Global
From €3471EUR$3,750USD£2,939GBP
- Report
- July 2024
- 100 Pages
Global
From €3471EUR$3,750USD£2,939GBP
- Report
- June 2024
- 200 Pages
Global
From €7358EUR$7,950USD£6,230GBP
- Report
- July 2024
- 100 Pages
Global
From €3471EUR$3,750USD£2,939GBP
- Report
- March 2026
- 200 Pages
Japan
From €2581EUR$2,789USD£2,186GBP
- Report
- March 2026
- 200 Pages
Saudi Arabia
From €2581EUR$2,789USD£2,186GBP
- Report
- July 2025
- 350 Pages
Global
From €4580EUR$4,949USD£3,878GBP
- Report
- July 2025
- 350 Pages
Global
From €4580EUR$4,949USD£3,878GBP
- Report
- July 2025
- 250 Pages
Africa, Middle East
From €3581EUR$3,869USD£3,032GBP
- Report
- July 2025
- 250 Pages
Latin America
From €3581EUR$3,869USD£3,032GBP
- Report
- July 2025
- 250 Pages
Asia Pacific
From €3581EUR$3,869USD£3,032GBP
- Report
- July 2025
- 350 Pages
Global
From €4580EUR$4,949USD£3,878GBP
- Report
- July 2025
- 350 Pages
Global
From €4580EUR$4,949USD£3,878GBP
- Report
- July 2025
- 250 Pages
North America
From €3581EUR$3,869USD£3,032GBP
- Report
- July 2025
- 250 Pages
Europe
From €3581EUR$3,869USD£3,032GBP
- Report
- July 2025
- 350 Pages
Global
From €4580EUR$4,949USD£3,878GBP
- Report
- July 2025
- 200 Pages
India
From €2581EUR$2,789USD£2,186GBP
- Report
- July 2025
- 250 Pages
Latin America
From €3581EUR$3,869USD£3,032GBP
- Report
- June 2025
- 400 Pages
Global
From €4580EUR$4,949USD£3,878GBP

The Infusions and Injectables market is a segment of the pharmaceutical industry that focuses on the production and distribution of drugs that are administered through intravenous (IV) or intramuscular (IM) injections. These drugs are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases. The market is highly competitive, with a number of large pharmaceutical companies vying for market share.
The market is divided into two main segments: branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they are often more effective and have fewer side effects. Generic drugs are typically cheaper, but they may not be as effective or have as many side effects.
Some of the major players in the Infusions and Injectables market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. These companies are responsible for the production and distribution of a wide range of drugs, including cancer treatments, diabetes medications, and autoimmune therapies. Show Less Read more